Allopurinol may inhibit the metabolism of warfarin, possibly enhancing its anticoagulant effect. Allopurinol may interact in a similar manner with other oral anticoagulants.
MANAGEMENT: Patients on concomitant therapy should be monitored for excessive anticoagulation. The INR should be checked frequently and dosage adjusted accordingly when allopurinol is added to an anticoagulant regimen. Patients should be advised to promptly report any signs of bleeding to their physician, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Prevention of Thromboembolism in Atrial Fibrillation - I had an abilation in February and am having?
Posted 14 Aug 2009 • 3 answers
Posted 17 Sep 2009 • 1 answer
Posted 22 Mar 2012 • 1 answer
Posted 16 May 2013 • 3 answers
Posted 3 Nov 2013 • 2 answers